Wednesday - March 04, 2026

Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Amyotrophic Lateral Sclerosis pipeline constitutes 70+ key companies continuously working towards developing 80+ Amyotrophic Lateral Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

Celiac Disease Market: Expanding Revenue Landscape to 2034 – DelveInsight | Zedira, Dr. Falk Pharma, Takeda, ImmunoGenX, Provention Bio, Sanofi, Topas Therapeutics GmbH, Pfizer

The Key Celiac Disease Companies in the market inlcude – Takeda, AnokionSA, Mozart Therapeutics, AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical Co., Ltd., Calypso Biotech, ImmunogenX, Inc., Amgen Inc., and others.   DelveInsight’s “Celiac Disease Market Insights, Epidemiology, and Market … Continue reading

Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Endometriosis Pain pipeline constitutes 5+ key companies continuously working towards developing 5+ Endometriosis Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading